Merck KGaA (OTCMKTS:MKKGY) Sees Large Decline in Short Interest

Merck KGaA (OTCMKTS:MKKGY) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 400 shares, a decline of 75.0% from the November 30th total of 1,600 shares. Based on an average daily volume of 280,200 shares, the short-interest ratio is currently 0.0 days.

Merck KGaA Stock Down 0.1 %

Merck KGaA stock traded down $0.02 during midday trading on Friday, reaching $29.08. The company’s stock had a trading volume of 121,440 shares, compared to its average volume of 75,991. The business has a 50-day simple moving average of $30.85 and a 200-day simple moving average of $33.87. Merck KGaA has a fifty-two week low of $28.29 and a fifty-two week high of $39.17. The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The company has a market cap of $18.79 billion, a P/E ratio of 17.95, a P/E/G ratio of 2.32 and a beta of 0.93.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group started coverage on Merck KGaA in a report on Thursday, September 19th. They issued a “buy” rating for the company.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.